It also revealed that outside the US there are several class actions and in excess of 100 personal injury cases pending against GSK in Canada, along with a class action in Israel. In this video ...
Health Canada has granted approval for GlaxoSmithKline’s (GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in adults with moderate-to-severe anaemia. The once-daily, oral treatment is ...
Hosted on MSN1mon
GSK's belantamab mafodotin reduced death risk by 42% in studyGSK (NYSE:GSK) reported that a study showed its ... China, United Kingdom, Canada and Switzerland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback